Human-virus interactions represent a dynamic and intricate relationship between the host organism and various viral pathogens. At the molecular level, viruses employ diverse strategies to enter host cells, evade immune detection, and hijack cellular machinery for replication. Host cells, in turn, deploy an elaborate array of defense mechanisms to recognize, neutralize, and eliminate viral invaders. Recognition of viruses by the host's innate immune system involves pattern recognition receptors (PRRs) that detect conserved viral structures known as pathogen-associated molecular patterns (PAMPs). This recognition triggers signaling cascades leading to the activation of antiviral responses, including the release of interferons and the recruitment of immune cells. The adaptive immune system, involving T and B lymphocytes, further contributes to specific antiviral responses, generating memory cells for long-term immunity. Viruses have evolved mechanisms to counteract host immune defenses, including modulation of host cell signaling, evasion of immune surveillance, and interference with antigen presentation. Some viruses can establish persistent infections by evading immune clearance, leading to chronic diseases. Research into human-virus interactions encompasses a wide range of viruses, including influenza, human immunodeficiency virus (HIV), herpesviruses, and emerging pathogens. Understanding the molecular intricacies of these interactions informs the development of antiviral therapies, vaccines, and strategies for managing viral infections.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain